Clinician reports disruptions in patient care after Flovent discontinuation, suggesting need for support during formulary changes.
Pediatric clinicians who care for children with asthma reported significant disruptions to patient care following the discontinuation of Flovent. These findings underscore the need for systems-level support of clinicians during major formulary transitions to minimize disruptions, particularly within pediatric asthma.
No takes yet. Share an insight, caveat, or question.
Saint‐Fleur et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: